Welcome to LookChem.com Sign In|Join Free
  • or
Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate is an organic compound characterized by the molecular formula C10H8ClNO2. It is a derivative of the heterocyclic compound pyrrolo[2,3-b]pyridine, which is frequently utilized in pharmaceutical research. Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate holds potential in medicinal chemistry, primarily as a precursor or intermediate for the synthesis of pharmaceutical compounds. Its unique structure and properties make it a promising candidate for further study and potential application in the development of new drugs, with its biological activities still awaiting comprehensive exploration.

951625-93-7

Post Buying Request

951625-93-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

951625-93-7 Usage

Uses

Used in Pharmaceutical Research:
Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the creation of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate is utilized as a precursor in the development of novel therapeutic agents. Its potential role in drug discovery is attributed to its ability to be modified and incorporated into diverse molecular frameworks, thereby enhancing the pharmacological properties of the resulting compounds.
Used in Drug Development:
Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate is employed in drug development as a building block for designing new pharmaceutical entities. Its incorporation into drug molecules can potentially lead to improved efficacy, selectivity, and safety profiles, making it a valuable asset in the quest for innovative treatments.
Used in Biological Research:
Methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate is also used in biological research to explore its potential biological activities. As its interactions with biological systems are not yet fully understood, ongoing research aims to uncover its capabilities, which may include effects on cellular processes, signaling pathways, or other biological mechanisms relevant to human health and disease.

Check Digit Verification of cas no

The CAS Registry Mumber 951625-93-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,6,2 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 951625-93:
(8*9)+(7*5)+(6*1)+(5*6)+(4*2)+(3*5)+(2*9)+(1*3)=187
187 % 10 = 7
So 951625-93-7 is a valid CAS Registry Number.

951625-93-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate

1.2 Other means of identification

Product number -
Other names 4-Chloro-7-azaindole-5-carboxylic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:951625-93-7 SDS

951625-93-7Relevant academic research and scientific papers

PYRAZOLOPYRIMIDINES AS INHIBITORS OF GLUCOCORTICOID RECEPTOR TRANSLOCATION

-

, (2016/08/23)

Provided herein are compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of Glucocorticoid Receptor (GR) translocation. Furthermore, the subject compounds and compositions are useful for the treatment of diseases involved in the hypothalamic-pituitary-adrenal (HPA) axis.

THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS

-

Page/Page column 24, (2012/04/23)

The invention provides a novel chemical series of formula I, as well as methods of use thereof for binding to the benzodiazepine site of the GABAA receptor and negatively modulating the α5 subtype of GABAA, and use of the compound of

HETEROCYCLIC TYROSINE KINASE INHIBITORS

-

, (2012/05/19)

The present invention provides compounds useful as inhibitors of Tec family kinases, compositions thereof, and methods of using the same. In certain embodiments, the present invention provides pharmaceutical formulations comprising provided compounds. In certain embodiments, the present invention provides a method of decreasing enzymatic activity of a Tec kinase family member. In some embodiments, such methods include contacting a Tec kinase family member with an effective amount of a Tec kinase family member inhibitor. In certain embodiments, the present invention provides a method of treating a disorder responsive to Tec kinase family inhibition in a subject in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 951625-93-7